AVIVA PLITTMAN: Open Payments
NPI 1780270355 · HACKENSACK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$579 in 30 payments from 7 companies in 2025. Trend: 2023 $169 · 2024 $494 · 2025 $579
Food & beverage: $579
| Company | Payments | Amount |
|---|---|---|
| Fresenius USA Marketing, Inc. | 10 | $194 |
| Travere Therapeutics, Inc. | 6 | $111 |
| Novartis Pharmaceuticals Corporation | 5 | $91 |
| AstraZeneca Pharmaceuticals LP | 3 | $55 |
| Novo Nordisk Inc | 2 | $51 |
| Lilly USA, LLC | 2 | $40 |
| Renalytix AI, Inc. | 2 | $36 |
Products named: VELPHORO, FARXIGA, KIDNEYINTELX BLOOD COLLECTION CONVENIENCE KIT, ZEPBOUND, Wegovy, MOUNJARO.
Industry payments across NJ — which companies pay providers there.
